Clinical Trial Update: Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase adjuvant trial of an alpha-lactalbumin vaccine in triple-negative breast cancer (Stage IIA-IIIC) is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Alpha-lactalbumin vaccine (alpha-lactalbumin vaccine)

Snippet

Sponsor: George T. Budd | Conditions: Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING